Literature DB >> 22446070

Mandibular metastases as first clinical sign of an occult male breast cancer.

L M Gonzalez-Perez1, P Infante-Cossio, S Crespo-Torres, F Sanchez-Gallego.   

Abstract

A 73-year-old man presented with a painful swelling of the left temporomandibular joint with no other symptoms. Panoramic radiography showed an osteolytic lesion in the left mandibular body, while magnetic resonance imaging provided the most accurate view of an osteolytic lesion in the left condyle. Skeletal scintigraphy showed increased uptake in the mandibular anatomical area. A diagnosis of metastatic breast adenocarcinoma was made from mandibular biopsies which proved to be ductal carcinoma, with no evidence of any other metastases. Clinicopathologic features of this case are reviewed.
Copyright © 2012 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22446070     DOI: 10.1016/j.ijom.2012.02.018

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  4 in total

1.  A case of HER2-positive male occult breast carcinoma with skin and lymph node metastases that exhibited complete response to trastuzumab monotherapy.

Authors:  Kouichi Kuninaka; Ryo Takahashi; Yutaka Nakagawa; Tadashi Nishimaki
Journal:  Clin Case Rep       Date:  2017-03-17

Review 2.  Metastasis to the Jawbones: A review of 453 cases.

Authors:  Soussan Irani
Journal:  J Int Soc Prev Community Dent       Date:  2017-03-29

3.  Metastasis in the mandibular condyle: a case report.

Authors:  Mina Dodo; Masahiro Kumagai; Yuta Kato; Hisashi Hirakawa; Takeyoshi Koseki
Journal:  J Med Case Rep       Date:  2017-11-16

Review 4.  An Update on the General Features of Breast Cancer in Male Patients-A Literature Review.

Authors:  Sinziana Ionescu; Alin Codrut Nicolescu; Marian Marincas; Octavia-Luciana Madge; Laurentiu Simion
Journal:  Diagnostics (Basel)       Date:  2022-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.